# Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease).

> **NCT04937556** · NA · COMPLETED · sponsor: **ProbiSearch SL** · enrollment: 41 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic: Lactobacillus salivarius + Vit D + Zinc
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04937556
- **Lead sponsor:** ProbiSearch SL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-25
- **Primary completion:** 2022-03-25
- **Final completion:** 2022-04-30
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2022-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04937556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04937556, "Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease).". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04937556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
